ClinicalTrials.gg
RecruitingNCT07810192Updated Sep 9, 2026

Randomized Assessor-Masked Trial of Moderate Graduated Compression Stockings for Popliteal Vein Dilation During Long-Haul Economy-Class Air Travel After Aesthetic Surgery

An interventional study of Enoxaparine and Knee-High Graduated Compression Stockings in Physiologic Venous Dilation and Air Travel, sponsored by Research Inc. Recruiting at 1 site in Colombia. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Research Inc · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 2 years 8 months after the study started (first participant enrolled Jan 2024, registered Sep 2026).
  • Started Jan 2024; still recruiting 2 years 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This randomized assessor-masked trial will evaluate whether knee-high moderate graduated compression stockings reduce popliteal vein dilation during long-haul economy-class air travel to Bogota. Participants will be assigned to stockings or no stockings and will undergo bilateral ultrasound before flight, within 2 hours after arrival, and at 24 and 48 hours. The primary outcome is the between-group difference in change in mean bilateral popliteal vein diameter from preflight baseline to arrival.

Read the detailed description

Eligible economy-class travelers will be randomized before departure. The intervention group will wear properly fitted knee-high graduated compression stockings from approximately 1 hour before boarding through the arrival ultrasound; the control group will not use lower-limb compression. A masked ultrasound assessor will obtain standardized bilateral diameter and cross-sectional-area measurements before flight and at arrival, 24 hours, and 48 hours. Adherence, movement, hydration, symptoms, and skin effects will be recorded. Intention-to-treat mixed models will estimate immediate and persistent treatment effects.

02

Conditions studied

  • Physiologic Venous Dilation
  • Air Travel

Keywords

  • Compression Stockings
  • Air Travel
  • Popliteal Vein
  • Duplex Ultrasound
  • Medical Tourism
03

In context

Lead sponsor

Research Inc is the lead sponsor of 24 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 65 years.
  • Economy-class commercial itinerary to Bogota with at least 4 hours of total airborne time.
  • No clinical indication that mandates or prohibits compression stockings.
  • Ability to obtain the assigned stocking before boarding and wear it as instructed.
  • Standardized preflight and postarrival ultrasounds completed before surgery.
  • Written .

Exclusion criteria

Exclusion Criteria:

  • Current deep venous thrombosis, therapeutic anticoagulation, or severe peripheral arterial disease.
  • Significant lower-limb skin disease, ulceration, neuropathy, or deformity preventing safe stocking use.
  • Pregnancy.
  • Planned use of another compression device during the flight.
  • Surgery or major intravenous fluid therapy before completion of the 48-hour examination.
  • Inability to complete preflight ultrasound or follow assigned treatment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
160 participants (estimated)

Study arms

  • Experimental
    Moderate Compression Stockings

    Participants wear properly fitted knee-high graduated compression stockings during the qualifying flight, beginning approximately 1 hour before boarding and removing them after the arrival ultrasound. all patients got enoxaparin to prevent blood clots

    Drug: Enoxaparine · Device: Knee-High Graduated Compression Stockings · Diagnostic Test: Standardized Bilateral Popliteal Vein Ultrasound

  • Active comparator
    No Compression Stockings

    Participants do not wear compression stockings or another lower-limb compression device during the qualifying flight. All patients got enoxaparin to prevent blood clots

    Drug: Enoxaparine · Diagnostic Test: Standardized Bilateral Popliteal Vein Ultrasound

Interventions

  • All patients got enoxaparin to prevent blood clots

  • DeviceKnee-High Graduated Compression Stockings

    PROPOSED pressure class: 20-30 mmHg at the ankle, appropriately sized according to calf and ankle circumference, worn from approximately 1 hour before boarding until completion of the arrival ultrasound. The final product, pressure class, fitting method, and wear instructions must be confirmed. Linked arm/group(s): Moderate Compression Stockings.

  • Diagnostic testStandardized Bilateral Popliteal Vein Ultrasound

    Triplicate bilateral diameter and cross-sectional-area measurements after a standardized rest period, with compressibility and flow assessment by an assessor masked to allocation. Linked arm/group(s): Moderate Compression Stockings, No Compression Stockings.

06

What researchers measure

Primary outcomes

  1. Difference in Change in Mean Bilateral Popliteal Vein Diameter

    Between-group difference in baseline-to-arrival change in the mean of triplicate anteroposterior diameter measurements from both legs, reported in millimeters and percent change.

    Time frame: Within 24 hours before departure and within 2 hours after arrival at the study site. 2 days

Secondary outcomes

  1. Incidence of Stocking-Related Adverse Effects

    Proportion with skin injury, numbness, clinically significant pain, intolerance, or early removal attributed to the stocking.

    Time frame: From stocking application through 24 hours after arrival. 5 days

  2. Incidental Venous Thrombosis or Abnormal Compressibility

    Number and proportion with an ultrasound abnormality requiring urgent clinical assessment.

    Time frame: From preflight baseline through 48 hours after arrival - 1 week

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Hoyos AE, Ramirez B, Benavides J, Perez Pachon ME, Varela A. Aeromedical Considerations for Patient Safety in Aesthetic Medical Tourism. Aerosp Med Hum Perform. 2024 Oct;95(10):765-770. doi: 10.3357/AMHP.6432.2024. PubMed 39431700 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2024 to primary completion in Sep 2026, 32 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2026
First posted
Sep 9, 2026
StartActual
Jan 1, 2024
Primary completionActual
Sep 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Sep 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07810192
Lead sponsor
Research Inc
Responsible party
Sponsor
First posted
Sep 9, 2026
Start date
Jan 1, 2024
Primary completion
Sep 1, 2026
Completion
Dec 1, 2026 (estimated)
Last update
Sep 9, 2026

Study contacts

Hugo Aguilar, MD, Plastic surgeon
Contact
havplasticacademy@gmail.com
+57 301 6918526
Hugo Aguilar
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion